World No-Tobacco Day 2017: Women Against Lung Cancer in Europe’s European Union Event on Primary Prevention

Changing Treatment Paradigm for ALK-Positive Lung Cancer

Prof. Nir Peled, MD, PhD, FCCP

Steven M. Keller, MD

Robert J. Cerfolio, MD, MBA

Role of Molecular Testing for AHCP Caring for Patients with NSCLC

ELCC 2017 Unveils New Research Regarding Screening, Immunotherapy, Treatment Planning, and More

Clinical Labeling in Medicinal Products: An Interview With Dr. David Planchard About the Effects of BRAF Mutations on Non-small Cell Lung Cancer Outcomes and Therapeutic Selection

IASLC Atlas of PD-L1 Immunohistochemistry Testing in Lung Cancer

IASLC Thoracic Oncology (2nd ed.)

NCI Corner - Interview with Matthew Holderfield, PhD